Factors Associated With Treatment Escalation for Psoriasis: An Analysis of Electronic Health Records Data

Author:

Rhoads Jamie L. W.1ORCID,Malatestinic William N.2,Burge Russel2ORCID,Ganz Michael L.3ORCID,Duffin Kristina C.1ORCID

Affiliation:

1. Department of Dermatology, University of Utah, Salt Lake City, UT, USA

2. Lilly Corporate Center, Eli Lilly USA, Indianapolis, IN, USA

3. Evidera, Inc, Waltham, MA, USA

Abstract

Background Electronic health records (EHRs) offer the possibility of using data entry templates to simultaneously document routine clinical care and capture disease-specific measures as discrete data elements that can be used for health services research (HSR). The objective of this study was to determine factors associated with meaningful treatment escalation (MTE) of psoriasis as a pilot study for future real-world HSR studies. Methods We conducted a retrospective, observational cohort study of psoriasis patients by using data collected during routine clinical care from an EHR using EpiCare® SmartForms. The psoriasis SmartForm records psoriasis disease severity measures and descriptive findings to generate visit notes. These data were extracted and analyzed to identify factors associated with MTE, defined as changing or adding, phototherapy, systemic, or biologic therapy. Results 473 psoriasis patients met study criteria; 239 underwent MTE between their first and third observed visits. Patients who experienced MTE had more severe disease at Visit 1—assessed by BSA, pPGA, oPGA, and a patient-reported disease severity measure--than patients who did not experience MTE. Other factors associated with MTE included use of topicals only or no active treatment at Visit 1, palmoplantar disease, and involvement of other difficult-to-treat body areas. Patients who underwent MTE experienced larger improvements in disease severity than those who did not. Conclusions This study highlights how data collected during routine clinical practice can be readily used for real-world retrospective HSR when disease measures are captured as discrete elements. This approach could provide a cost-effective platform to conduct real-world HSR.

Funder

Eli Lilly and Company

Publisher

SAGE Publications

Subject

Dermatology,Rheumatology

Reference17 articles.

1. Pathophysiology, Clinical Presentation, and Treatment of Psoriasis

2. U.S. Food and Drug Administration. Risk evaluation and mitigation strategies. White Oak, TX: U.S. Food and Drug Administration; 2021. https://www.fda.gov/drugs/drug-safety-and-availability/risk-evaluation-and-mitigation-strategies-rems#:∼:text=A_Risk_Evaluation_and_Mitigation,the_medication_outweigh_its_risks. Published 2021. Accessed January 31, 2022.

3. Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis

4. The Evolving Use of Electronic Health Records (EHR) for Research

5. Leveraging electronic health records for data science: common pitfalls and how to avoid them

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3